Unique mechanism of action of Alzheimer's drugs on brain nicotinic acetylcholine receptors and NMDA receptors.

[1]  S. Moriguchi,et al.  Potentiation of N-Methyl-d-aspartate-Induced Currents by the Nootropic Drug Nefiracetam in Rat Cortical Neurons , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2]  Katrin Engelmann,et al.  cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner , 2002, Oncogene.

[3]  J. Lindstrom,et al.  Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. , 2001, Molecular pharmacology.

[4]  L. Martin,et al.  N-Methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease , 2001, Journal of the Neurological Sciences.

[5]  W. Sweileh,et al.  Multistep expression and assembly of neuronal nicotinic receptors is both host-cell- and receptor-subtype-dependent. , 2000, Brain research. Molecular brain research.

[6]  Y. Marunaka,et al.  cAMP stimulates Na+ transport in rat fetal pneumocyte: involvement of a PTK- but not a PKA-dependent pathway. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[7]  T. Narahashi,et al.  Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam , 1999, Brain Research.

[8]  T. Lewis,et al.  The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type , 1997, The Journal of physiology.

[9]  J. Mcculloch,et al.  123Iodo-MK-801: a spect agent for imaging the pattern and extent of glutamate (NMDA) receptor activation in Alzheimer's disease. , 1997, Journal of psychiatric research.

[10]  N. Millar,et al.  Host Cell‐Specific Folding and Assembly of the Neuronal Nicotinic Acetylcholine Receptor α7 Subunit , 1997, Journal of neurochemistry.

[11]  D. Colquhoun,et al.  Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single‐channel behaviour. , 1997, The Journal of physiology.

[12]  B. Mlinar,et al.  Adrenocorticotropic hormone and cAMP inhibit noninactivating K+ current in adrenocortical cells by an A-kinase-independent mechanism requiring ATP hydrolysis , 1996, The Journal of general physiology.

[13]  S. Hashtroudi,et al.  d-Cycloserine enhances implicit memory in Alzheimer patients , 1996, Neurology.

[14]  F. Fonnum,et al.  Role of Glutamate and Glutamate Receptors in Memory Function and Alzheimer's Disease a , 1995, Annals of the New York Academy of Sciences.

[15]  S. Ikeda,et al.  VIP inhibits N-type Ca2+ channels of sympathetic neurons via a pertussis toxin-insensitive but cholera toxin-sensitive pathway , 1994, Neuron.

[16]  M. Yoshii,et al.  Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells , 1994, Brain Research.

[17]  D. Olton,et al.  D-cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats , 1994, Neurobiology of Aging.

[18]  T. Narahashi,et al.  Use-dependent pentobarbital block of kainate and quisqualate currents , 1993, Brain Research.

[19]  J. Mendels,et al.  Milacemide: A Placebo‐Controlled Study in Senile Dementia of the Alzheimer Type , 1992, Journal of the American Geriatrics Society.

[20]  S. Hashtroudi,et al.  Glycine prodrug facilitates memory retrieval in humans , 1991, Neurology.

[21]  J. Hardy,et al.  Glutamatergic neurotransmission in Alzheimer's disease. , 1990, Biochemical Society transactions.

[22]  G. Handelmann,et al.  Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents , 1989, Pharmacology Biochemistry and Behavior.

[23]  J. Penney,et al.  Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[3H]Glutamate Binding , 1987, Journal of neurochemistry.

[24]  F. Barrantes,et al.  Expression of a Neuronal Nicotinic Acetylcholine Receptor in Insect and Mammalian Host Cell Systems , 2004, Neurochemical Research.

[25]  T. Nishizaki,et al.  Presynaptic Nicotinic Acetylcholine Receptors As a Functional Target of Nefiracetam in Inducing a Long-lasting Facilitation of Hippocampal Neurotransmission , 2000, Alzheimer disease and associated disorders.

[26]  Y. Murashima,et al.  Cellular Mechanism of Action of Cognitive Enhancers: Effects of Nefiracetam on Neuronal Ca2+ Channels , 2000, Alzheimer disease and associated disorders.

[27]  T Narahashi,et al.  Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. , 1999, Molecular pharmacology.

[28]  T. Nishizaki,et al.  Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. , 1998, Molecular pharmacology.

[29]  G. Lynch,et al.  The nature and causes of hippocampal long-term potentiation. , 1990, Progress in brain research.